Location: TRI Auditorium, Level 2, 37 Kent St Woolloongabba
Event Category: Symposium
Date & Time: 21 Nov 2014 9:00am to 5:00pm
Want to find out who’s collaborating with who; the latest breakthroughs and innovations; and whether anyone has managed to translate these into treatments? If you do, register now for the TRI Awards Symposium.
The winner of the TRI National Prize for translational research will join the winners of the four TRI Awards to present the outcomes of their winning projects. The day will include presentations from researchers and clinicians that demonstrate other leading examples of collaboration, innovation, breakthroughs and translation.
The Symposium provides an excellent opportunity for those interested in the outcomes of bringing together nearly 700 researchers and clinicians from four partner institutes into one facility, collocated with a biopharmaceutical manufacturer, on the grounds of a major teaching hospital.
ScienceAlert Australia Neha Karl 14 November 2014
Taking care of yourself is about to get a whole lot easier, with the introduction of a new app that gives you personalised health information based on your DNA.
ABC News Kym Agius 14 November 2014
Queensland researchers have made a breakthrough in leukaemia treatment which cuts the chance of patients contracting a potentially fatal disease during treatment. During trials patients were given a drug post-transplant to inhibit production of a protein that simulates the body’s response to trauma.
ABC News November 11, 2014 Sophie Scott
People having their vitamin D levels tested will face new restrictions on rebates after a massive jump in the number of tests being carried out. Continue reading…
USA Today Peter Eisler 6 November 2014
Several leading manufacturers of high-tech diagnostic devices have alerted hospital laboratories that they will restrict service, support and warranties for equipment used to test blood and organ functions for Ebola patients. Fearing infections, some decline to have their technicians perform tuning and maintenance the expensive devices often require. Others advise labs to quarantine the equipment after use on Ebola patients or even destroy it – a policy that one company’s own CEO calls “the dumbest” approach imaginable.
Radio National Norman Swan 10 November 2014
A prospective diagnostic study from the International Ovarian Tumour Analysis (IOTA) group looked at whether they can preoperatively predict the likelihood of an ovarian tumour being benign or malignant.
Listen, download audio or read transcript
(University of Washington Health Sciences/UW Medicine 10 November 2014) Thousands of never-before-seen genetic variants in the human genome have been uncovered using a new genome sequencing technology. These discoveries close many human genome mapping gaps that have long resisted sequencing. The technique, called single-molecule, real-time DNA sequencing, may now make it possible for researchers to identify potential genetic mutations behind many conditions whose genetic causes have long eluded scientists
Read EurekAlert Summary
Request the source article from Information & Research Services (QH Staff only)